PSORS1C1 may be involved in rheumatoid arthritis

Immunology Letters

Volumn 153, Issue 1-2, 2013, Pages 9-14

  Sun, Hongjun ^a   Xia, Yifang ^a,b   Wang, Lin ^b   Wang, Yuejian ^a   Chang, Xiaotian ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

Author keywords

CDSN; Interleukin 1 (IL 1 ).; Interleukin 17 (IL 17); PSORS1C1; Rheumatoid arthritis (RA)

Indexed keywords

BIOLOGICAL MARKER; CORNEODESMOSIN; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; PSORIASIS SUSCEPTIBILITY 1 CANDIDATE 1 PROTEIN; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; AGED; ANKYLOSING SPONDYLITIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLAST; GENE; GENE EXPRESSION; GENE FREQUENCY; GENE LOCUS; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS SUSCEPTIBILITY 1 CANDIDATE 1 GENE; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM; SYNOVIUM; WESTERN BLOTTING;

CDSN; INTERLEUKIN-1Β (IL-1Β).; INTERLEUKIN-17 (IL-17); PSORS1C1; RHEUMATOID ARTHRITIS (RA);

ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; C-REACTIVE PROTEIN; CELL PROLIFERATION; CELLS, CULTURED; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLYCOPROTEINS; HUMANS; INTERLEUKIN-17; INTERLEUKIN-1BETA; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEINS; PSORIASIS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SYNOVIAL MEMBRANE; YOUNG ADULT;

EID: 84880021098     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2013.06.001     Document Type: Article

References (26)

1. Holm S.J., Carlén L.M., Mallbris L., Ståhle-Bäckdahl M., O'Brien K.P. Polymorphisms in the SEEK1 and SPR1 genes on 6p21.3 associate with psoriasis in the Swedish population. Exp Dermatol 2003, 12:435-444.
2. Zhang X.J., He P.P., Wang Z.X., Zhang J., Li Y.B., Wang H.Y., et al. Evidence for a major psoriasis susceptibility locus at 6p21 (PSORS1) and a novel candidate region at 4q31 by genome-wide scan in Chinese Hans. J Invest Dermatol 2002, 119:1361-1366.
3. Gandhi G., Buttar B.S., Albert L., Hasan Q., Aggarwal R.K. Psoriasis-associated genetic polymorphism in North Indian population in the CCHCR1 gene and in a genomic segment flanking the HLA-C region. Dis Markers 2011, 31:361-370.
4. Kim J.J., Hong S.J., Hong Y.M., Kim S., Kang M.J., Kim K.J., et al. Genetic variants in the HLA-G region are associated with Kawasaki disease. Hum Immunol 2008, 69:867-871.
5. Chang Y.T., Liu H.N., Shiao Y.M., Lin M.W., Lee D.D., Liu M.T., et al. A study of PSORS1C1 gene polymorphisms in Chinese patients with psoriasis. Br J Dermatol 2005, 153:90-96.
6. Day M.S., Nam D., Goodman S., Su E.P., Figgie M. Psoriatic arthritis. J Am Acad Orthop Surg 2012, 20:28-37.
7. Tillett W., de-Vries C., McHugh N.J. Work disability in psoriatic arthritis: a systematic review. Rheumatology (Oxford) 2012, 51:275-283.
8. Brewerton D.A., James D.C. The histocompatibility antigen (HL-A 27) and disease. Semin Arthritis Rheum 1975, 4:191-207.
9. Rahman P., Butt C., Siannis F., Farewell V.T., Peddle L., Pellett F.J., et al. Association of SEEK1 and psoriatic arthritis in two distinct Canadian populations. Ann Rheum Dis 2005, 64:1370-1372.
10. Emi Aikawa N., de Carvalho J.F., Artur Almeida Silva C., Bonfá E. Immunogenicity of anti-TNF-alpha agents in autoimmune diseases. Clin Rev Allergy Immunol 2010, 38:82-89.
11. The International HapMap Consortium Integrating ethics and science in the International HapMap Project. Nat Rev Genet 2004, 5:467-475.
12. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
13. Li Z., Zhang Z., He Z., Tang W., Li T., Zeng Z., et al. A partition-ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis. Cell Res 2009, 19:519-523.
14. Karmakar S., Kay J., Gravallese E.M. Bone damage in rheumatoid arthritis: mechanistic insights and approaches to prevention. Rheum Dis Clin North Am 2010, 36:385-404.
15. Koenders M.I., Joosten L.A., van den Berg W.B. Potential new targets in arthritis therapy: interleukin (IL)-17 and its relation to tumour necrosis factor and IL-1 in experimental arthritis. Ann Rheum Dis 2006, 65:iii29-iii33.
16. Moon Y.M., Yoon B.Y., Her Y.M., Oh H.J., Lee J.S., Kim K.W., et al. IL-32 and IL-17 interact and have the potential to aggravate osteoclastogenesis in rheumatoid arthritis. Arthritis Res Ther 2012, 14:R246.
17. Baek S.H., Lee S.G., Park Y.E., Kim G.T., Kim C.D., Park S.Y. Increased synovial expression of IL-27 by IL-17 in rheumatoid arthritis. Inflamm Res 2012, 61:1339-1345.
18. Park Y.E., Woo Y.J., Park S.H., Moon Y.M., Oh H.J., Kim J.I., et al. IL-17 increases cadherin-11 expression in a model of autoimmune experimental arthritis and in rheumatoid arthritis. Immunol Lett 2011, 140:97-103.
19. Wang L., Zheng Y., Xu H., Yan X., Chang X. Investigate pathogenic mechanism of TXNDC5 in rheumatoid arthritis. PLoS ONE 2013, 8:e53301.
20. Ensenauer R., Hartl D., Vockley J., Roscher A.A., Fuchs U. Efficient and gentle siRNA delivery by magnetofection. Biotech Histochem 2011, 86:226-231.
21. Bouxsein N.F., McAllister C.S., Ewert K.K., Samuel C.E., Safinya C.R. Structure and gene silencing activities of monovalent and pentavalent cationic lipid vectors complexed with siRNA. Biochemistry 2007, 46:4785-4792.
22. Zhang M., Bai C.X., Zhang X., Chen J., Mao L., Gao L. Downregulation enhanced green fluorescence protein gene expression by RNA interference in mammalian cells. RNA Biol 2004, 1:74-77.
23. Hiroi N., Funahashi A., Kitano H. Comparative studies of suppression of malignant cancer cell phenotype by antisense oligo DNA and small interfering RNA. Cancer Gene Ther 2006, 13:7-12.
24. Gough S.C., Simmonds M.J. The HLA region and autoimmune disease: associations and mechanisms of action. Curr Genomics 2007, 8:453-465.
25. Orrù S., Giuressi E., Carcassi C., Casula M., Contu L. Mapping of the major psoriasis-susceptibility locus (PSORS1) in a 70-Kb interval around the corneodesmosin gene (CDSN). Am J Hum Genet 2005, 76:164-171.
26. Capon F., Allen M.H., Ameen M., Burden A.D., Tillman D., Barker J.N., et al. A synonymous SNP of the corneodesmosin gene leads to increased mRNA stability and demonstrates association with psoriasis across diverse ethnic groups. Hum Mol Genet 2004, 13:2361-2368.